We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity. Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity.
Enrolling Patients in Global Phase 3 CoMpass Trial in Small Choroidal Melanoma and Indeterminate Lesions; Granted SPA Agreement by FDA Data Expected Mid-2024 from Ongoing Phase 1 Trial in Bladder...
Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.07 | 0.99573257468 | 7.03 | 7.4 | 6.95 | 122474 | 7.13403876 | CS |
4 | -0.6 | -7.79220779221 | 7.7 | 8.133 | 6.95 | 128770 | 7.4083189 | CS |
12 | -0.73 | -9.32311621967 | 7.83 | 9.72 | 6.95 | 189837 | 7.83938411 | CS |
26 | -1.5 | -17.4418604651 | 8.6 | 12.35 | 5.99 | 206706 | 8.00962734 | CS |
52 | -1.85 | -20.6703910615 | 8.95 | 13.5 | 5.99 | 137449 | 8.74238646 | CS |
156 | -7 | -49.6453900709 | 14.1 | 26.16 | 5.99 | 111609 | 11.4771585 | CS |
260 | -7 | -49.6453900709 | 14.1 | 26.16 | 5.99 | 111609 | 11.4771585 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions